Metraipolis › archive › dc_68495403a952

Real-World Evidence on Low-Dose Olanzapine (≤1.25 mg) for Personalized Antipsychotic Dosing — Europe PMC PMID:40863442

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40863442
DOI
10.3390/jpm15080380
License (as archived)
solo-consultazione
Archived
2026-11-10T14:36:20.978Z
SHA-256 of the archived text
9712930b37413ea4f35075e43a94f54f2dc36678866ecb937094b25973f5dc0b
Stable URL of this page
https://metraipolis.com/documento/dc_68495403a952

How to cite

Real-World Evidence on Low-Dose Olanzapine (≤1.25 mg) for Personalized Antipsychotic Dosing — Europe PMC PMID:40863442 — Europe PMC (en), https://europepmc.org/article/MED/40863442 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_68495403a952 (Metraipolis archive dc_68495403a952, sha256 9712930b37413ea4f35075e43a94f54f2dc36678866ecb937094b25973f5dc0b)
BibTeX
@misc{dc68495403a952,
  title = {Real-World Evidence on Low-Dose Olanzapine (≤1.25 mg) for Personalized Antipsychotic Dosing — Europe PMC PMID:40863442},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40863442},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_68495403a952; sha256 9712930b37413ea4f35075e43a94f54f2dc36678866ecb937094b25973f5dc0b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40863442. Agents can read the archived copy with the MCP tool read_document.